Toward a Locally Deployable Agentic Co-Scientist: Small-Model Planning for Early-Stage Drug Discovery
cs.AI
Submitted: 2026-10-03
Updated: 2026-10-03
Comments: 22 pages, 4 figures. Accepted at the AI for Drug Discovery Workshop, NeurIPS 2026
License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
Terminology
Sources
- Docling Technical Report
- DiffDock: Diffusion Steps, Twists, and Turns for Molecular Docking
- The Llama 3 Herd of Models
- Gemma 3 Technical Report
- DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration
- BixBench: a Comprehensive Benchmark for LLM-based Agents in Computational Biology
- AI Agents in Drug Discovery
- Agent AI with LangGraph: A Modular Framework for Enhancing Machine Translation Using Large Language Models
- Qwen3 Technical Report
Related papers
- MAVEN-T: Reinforced Heterogeneous Distillation for Real-Time Multi-Agent Trajectory Prediction
- Model Discovery Agent: LLM-assisted Bayesian experiment design for data-efficient discovery of mechanistic world models
- Agents' Last Exam
- The Clinician's Veto: Navigating Trust, Liability, and Uncertainty in Autonomous AI Prescribing
- MindHelper: Closed-Loop Embodied Mental-State Reasoning for Precision Intervention
- Incumbent Advantage: Brand Bias and Cognitive Manipulation Dynamics in LLM Recommendation Systems